PMN — ProMIS Neurosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapValue Trap

Annual balance sheet for ProMIS Neurosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	R2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	Interim Report	ARS	ARS	ARS
Standards:	IFRS	USG	USG	USG	USG
Status:	fx Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	0.841	17	5.91	12.6	13.3
Net Total Accounts Receivable
Net Total Receivables	0.031	—	—	0.079	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	0.975	17.7	6.9	13.6	18.9
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.078	0.005	0	0	—
Net Intangible Assets
Long Term Investments
Total Assets	1.09	17.7	6.92	13.6	18.9
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	1.89	0.929	6.41	9.35	2.22
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	1.89	12.1	8.27	9.87	2.42
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-0.798	5.66	-1.35	3.75	16.5
Total Liabilities & Shareholders' Equity	1.09	17.7	6.92	13.6	18.9
Total Common Shares Outstanding